Skip to content
healthcare.dev

LISDEXAMFETAMINE DIMESYLATE

NDC 57664-083, LISDEXAMFETAMINE DIMESYLATE, tablet, chewable, from Sun Pharmaceutical Industries, Inc..

Product NDC
57664-083
Status
Listed
Labeler
Sun Pharmaceutical Industries, Inc.
Dosage form
TABLET, CHEWABLE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA214134
DEA schedule
CII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/57664-083 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LISDEXAMFETAMINE DIMESYLATE10 mg/1

Pharmacologic classes

Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]

Package NDCNDC-11Package
57664-083-8857664008388100 TABLET, CHEWABLE in 1 BOTTLE (57664-083-88)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/da3148af-f9b6-4725-adae-3595b4c7dc4b
  • NADAC price for package 57664008388

    GET /v1/drugs/nadac/57664008388

Use it

Look up 57664-083 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/57664-083 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 57664-083. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.